跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
OXERVATE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
OXERVATE
Authorized
STANDARD
OXERVATE
Dompe Farmaceutici SpA
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
a8f1d2cf1307dce0
Company
Dompe Farmaceutici SpA
Type
Standard
Approval Details
Approval Id
a8f1d2cf1307dce0
Drug Approval Canada Name
OXERVATE
Product Name
OXERVATE
Status
Cancelled Post Market
Status Date
2024-07-17
Original Market Date
2022-02-18
Din
02485613
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Ophthalmic
Schedule
Schedule D , Prescription
Ahfs
52:08.00
Atc Original
S01XA24 CENEGERMIN
Atc Name
s 01 xa 24
Aig Number
0161210002
Company Name
Dompe Farmaceutici SpA
Company Address
Via Santa Lucia, 6, Milano, Milan, Italy, 20122
Company Detail Path
/organization/dompe-farmaceutici-spa
Company Information
Pharmaceutical Company Name
Dompe Farmaceutici SpA
Country Name
Italy
Website
http://www.dompe.it
Active Ingredients
CENEGERMIN
0.002 %
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
a8f1d2cf1307dce0
Type
Standard
Back to Health Canada Approvals